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INTRODUCTION 
I t i s g e n e r a l l y a g r e e d t h a t : (a) massive numbers o f PMN l e u -
k o c y t e s a c c u m u l a t e a t s i t e s o f c h r o n i c i n f l a m m a t i o n ( 1 ) , and i n 
i n f l a m m a t o r y s y n o v i a l f l u i d s ( 2 ) , (b) t h e s e PMN l e u k o c y t e s r e l e -
ase e l a s t a s e (3) as w e l l as a number o f o t h e r enzymes and i n f l a m -
m a t o r y m e d i a t o r s (4) d u r i n g p h a g o c y t o s i s o r o t h e r mechanisms ( 5 ) , 
(c) s u b s t a n t i a l q u a n t i t i e s o f e l a s t a s e have been i d e n t i f i e d i n t h e 
synovium (6,7) o r , complexed t o n a t u r a l l y o c c u r i n g i n h i b i t o r s 
i n s y n o v i a l f l u i d s o f RA p a t i e n t s (8-12) o r p e n e t r a t e d i n t o t h e 
a r t i c u l a r c a r t i l a g e ( 1 3 , 1 4 ) . 
W i t h o u t e n t e r i n g t h e d e b a t e as t o w h e t h e r o r n o t l e u k o c y t i c 
e l a s t a s e i s r e s p o n s i b l e f o r t i s s u e d e s t r u c t i o n i n RA and o t h e r 
i n f l a m m a t o r y d i s e a s e s ( f o r a r e v i e w see B a r r e t t , r e f . 1 5 ) , we 
have t a k e n t h e f i n d i n g s l i s t e d above t o s u g g e s t t h a t l e u k o c y t i c 
e l a s t a s e r e l e a s e d a t s i t e s o f i n f l a m m a t i o n may l e a d t o e l e v a t e d 
plasma l e v e l s o f t h i s enzyme. 
I n d e e d , e l e v a t e d plasma l e v e l s o f l e u k o c y t e e l a s t a s e - a P I 
complexes have p r e v i o u s l y been o b s e r v e d (16) and s u b s e q u e n t l y 
f o l l o w e d up i n more d e t a i l (17) i n p a t i e n t s w i t h l e u k e m i a o r 
s e p t i c a e m i a . I n c r e a s e d l e v e l s o f e l a s t a s e - a M complexes were 
a l s o f o u n d i n s e p t i c a e m i c p a t i e n t s ( 1 8 ) . 
3 5 5 
3 5 6 H. P. SCHNEBLI ET AL. 
I n t h e p r e s e n t s t u d y we measured t h e plasma l e v e l s o f e l a -
s t a s e - a P I complexes by an i m m u n o l o g i c a l t e c h n i q u e (ELISA) 
(Method A) and o f a M bound e l a s t a s e w i t h a s y n t h e t i c chromo-
g e n i c s u b s t r a t e (Method B) i n RA p a t i e n t s (n=87) and h e a l t h y 
c o n t r o l s ( n = 2 4 ) . 
PATIENTS AND METHODS 
Twenty seven male and 60 f e m a l e p a t i e n t s s u f f e r i n g f r o m rheuma-
t o i d a r t h r i t i s a c c o r d i n g t o t h e c r i t e r i a o f t h e A m e rican Rheuma-
t i s m A s s o c i a t i o n were s t u d i e d . T h e i r d i s e a s e a c t i v i t y was assessed 
by a new m u l t i v a r i a t e a n a l y s i s c o m p r i s i n g t h e f o l l o w i n g c r i t e r i a : 
m o r n i n g s t i f f n e s s , p a i n s c a l e , g r i p s t r e n g t h , a r t i c u l a r i n d e x , 
h a e moglobin c o n c e n t r a t i o n and e r y t h r o c y t e s e d i m e n t a t i o n r a t e ( 1 9 ) . 
On t h e b a s i s o f t h e i r g l o b a l s c o r e i n t h e a n a l y s i s t h e p a t i e n t s 
were a s s i g n e d t o one o f f o u r g r ades o f d i s e a s e a c t i v i t y (MDAG 1 - 4 ) . 
B l o o d samples were drawn i n t o EDTA-coated t u b e s and c e n t r i f u g e d 
i m m e d i a t e l y i n o r d e r t o remove c e l l s ; plasma was t h e n s t o r e d a t 
-20° u n t i l assayed. 
L e v e l s o f i m m u n r e a c t i v e e l a s t a s e i n plasma were d e t e r m i n e d 
w i t h a newly d e v e l o p e d e n z y m e - l i n k e d immunoassay (ELISA) ( 1 2 , 2 0 ) . 
T h i s method (Method A) measures e x c l u s i v e l y t h e e l a s t a s e com-
p l e x e d t o a ^ P I . Plasma samples were i n c u b a t e d i n p l a s t i c t u b e s 
c o a t e d w i t h a n t i b o d i e s a g a i n s t e l a s t a s e . A f t e r w a s h i n g w i t h 
b u f f e r , t h e s u r f a c e f i x e d e l a s t a s e - a ^ P I complexes were r e a c t e d 
w i t h a n t i - a ^ P I a n t i b o d i e s l a b e l l e d w i t h a l k a l i n e p h o s p h a t a s e . 
Under t h e c o n d i t i o n s used, t h e e n z y m a t i c a c t i v i t y o f t h e a l k a l i n e 
p hosphatase (assayed w i t h p - n i t r o p h e n y l phosphate) was p r o p o r -
t i o n a l t o t h e c o n c e n t r a t i o n o f e l a s a t a s e - a P I complex i n t h e 
sample. (For d e t a i l s o f t h i s assay, see r e r . 2 0 ) . 
L e u k o c y t e e l a s t a s e a c t i v i t y i n plasma was measured by a 
m o d i f i c a t i o n (18) o f t h e p r o c e d u r e d e s c r i b e d e a r l i e r ( 2 1 ) . I n 
t h i s assay (Method B) t h e r e l e a s e o f p - n i t r o a n i l i n e f r o m Methoxy-
S u c c i n y l - L - A l a - L - A l a - L - P r o - L - V a l - p - N i t r o a n i l i d e (MeO-Suc-Ala-Ala-
Pro-Val-pNA), a h i g h l y s p e c i f i c chromogenic s u b s t r a t e f o r l e u k o c y -
t i c e l a s t a s e ( 2 2 ) , was d e t e r m i n e d p h o t o m e t r i c a l l y ; o - p h e n a n t h r o -
l i n e was i n c l u d e d t o i n h i b i t an u n r e l a t e d m e t a l dependent e l a s -
t a s e - l i k e enzyme (18, 2 3 ) . B r i e f l y , 0.2 ml o f plasma was d i l u t e d 
w i t h 0.2 ml o f b u f f e r c o n t a i n i n g t h e s u b s t r a t e and t h e m e t a l 
c h e l a t o r ; f i n a l c o n c e n t r a t i o n s : 0.1 M T r i s - H C l , pH 7.5, 1 mM 
MeO-Suc-Ala-Ala-Pro-Val-pNA and 10 mM o - p h e n a n t h r o l i n e . The 
m i x t u r e was i n c u b a t e d a t 37° f o r 1 t o 6 h o u r s and t h e r e a c t i o n . 
was s t o p p e d by t h e a d d i t i o n o f 1 ml t r i c h l o r o a c e t i c a c i d (7.5 % ) . 
P r e c i p i t a t e d p r o t e i n was removed by c e n t r i f u g a t i o n and t h e 
r e l e a s e d n i t r o a n i l i n e was t r a n s f o r m e d t o an azo-dye by t h e 
s e q u e n t i a l a d d i t i o n o f 25 \il each o f sodium n i t r i t e (1.8 %) , 
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ammonium sulphamate (9 %) and N - l - n a p h t y l e t h y l e n e - d i a m i n e d i - H C l 
(1.8 %) t o t h e s u p e r n a t a n t . The r e s u l t i n g c o l o r was measured a t 
550 nm. The c o r r e s p o n d i n g enzyme a c t i v i t y i s e x p r e s s e d i n nmoles/ 
ml/h o f s u b s t r a t e h y d r o l y z e d . 
RESULTS AND DISCUSSION 
The p r e s e n t s t u d y was u n d e r t a k e n t o d e t e r m i n e w h e t h e r t h e r e -
l e a s e o f l e u k o c y t e e l a s t a s e a t s i t e s o f a c t i v e i n f l a m m a t i o n i s r e -
f l e c t e d i n t h e plasma l e v e l s o f t h i s enzyme, and w h e t h e r t h i s may 
be d i a g n o s t i c a l l y u s e f u l i n RA. Two i n d e p e n d e n t methods f o r t h e 
d e t e r m i n a t i o n o f HLE plasma l e v e l s were employed. 
The d e s i g n o f t h e e n z y m e - l i n k e d immunoassay (20) ensu r e s t h a t 
o n l y HLE bound t o a - p r o t e i n a s e i n h i b i t o r was measured (Method A ) . 
I n o u r hands, t h e HLE l e v e l s i n c o n t r o l plasma were c o m p a t i b l e 
w i t h t h e p r e v i o u s l y p u b l i s h e d v a l u e s o f 84 _+ 25 ng/ml (20) and 
60 ng/ml (median v a l u e ) (24) u s i n g t h e same assay system. 
A 
o-l c-
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F i g . 1 HLE plasma l e v e l s measured i m m u n o l o g i c a l l y as a^PI 
complex i n 87 RA p a t i e n t s : c o m p arison w i t h MDAG ( A ) , 
a w e i g h t e d i n d e x o f d i s e a s e a c t i v i t y , o r w i t h t h e 
R i t c h i e a r t i c u l a r i n d e x ( B ) . 
The m a j o r i t y o f t h e plasma samples f r o m RA p a t i e n t s had 
c l e a r l y e l e v a t e d HLE-a P I l e v e l s ( F i g . 1A); 65 o f 87 samples 
r e v e a l e d v a l u e s more t h a n 2 s t a n d a r d d e v i a t i o n s above t h e no r m a l 
mean v a l u e . However, as can be seen i n t h e same f i g u r e , t h e HLE 
c o n c e n t r a t i o n i n plasma does n o t c o r r e l a t e w i t h t h e "mean d i s e a s e 
a c t i v i t y grade (MDAG)" ( 1 9 ) , a w e i g h t e d i n d e x based on 6 d i s e a s e 
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p a r a m e t e r s (see p a t i e n t s and methods) o r w i t h t h e R i t c h i e a r t i c u -
l a r i n d e x (25) a l o n e ( F i g . 1 B ) . I n t e r e s t i n g l y , i n t h e same 
p a t i e n t c o l l e c t i v e , C - r e a c t i v e p r o t e i n (CRP) l e v e l s c o r r e l a t e d 
w e l l , b o t h w i t h t h e MDAG and t h e R i t c h i e i n d e x ( 2 6 ) . 
B 
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F i g . 2 HLE plasma l e v e l s measured as enzymic a c t i v i t y o f a M 
complexes i n 87 RA p a t i e n t s : c o m p a r i s o n w i t h MDAG (Ä) 
o r w i t h t h e R i t c h i e a r t i c u l a r i n d e x ( B ) . 
The measurement o f e l a s t a s e a c t i v i t y i n plasma (Method B) i s 
based on t h e f a c t t h a t a^M bound p r o t e i n a s e s r e t a i n h y d r o l y t i c 
a c t i v i t y t o w a r d s low M s u b s t r a t e s , t h o u g h t h e y a r e u n a b l e t o 
a t t a c k most l a r g e ( p r o i e i n ) s u b s t r a t e s . As shown p r e v i o u s l y w i t h 
plasma f r o m s e p t i c a e m i c p a t i e n t s (18) , t h i s e l a s t a s e a c t i v i t y can 
be s e p a r a t e d f r o m t h e b u l k o f plasma p r o t e i n s on S e p h a c r y l S300. 
The a p p a r e n t m o l e c u l a r w e i g h t ( a p p r o x . 800 000 D a ) , t h e s u b s t r a t e 
s p e c i f i c i t y (MeO-Suc-Ala-Ala-Pro-Val-pNA) and t h e i n h i b i t i o n 
p a t t e r n ( i n s e n s i t i v e t o EDTA and o - p h e n a n t h r o l i n e , s e n s i t i v e t o 
PMSF and t h e e l a s t a s e s p e c i f i c i n h i b i t o r E g l i n C) i d e n t i f i e s t h i s 
a c t i v i t y as l e u k o c y t e e l a s t a s e - a M complex. Compared w i t h plasma 
f r o m 24 h e a l t h y c o n t r o l s , HLE a c t i v i t y was e l e v a t e d i n a number 
o f plasma samples f r o m RA p a t i e n t s (20 o u t o f 87 samples were 
e l e v a t e d more t h a n 2 s t a n d a r d d e v i a t i o n s above t h e n o r m a l mean) 
( F i g . 2A). 
However, a g a i n no c o r r e l a t i o n c o u l d be f o u n d between plasma 
HLE a c t i v i t y l e v e l s and d i s e a s e a c t i v i t y ( F i g . 2 ) . F u r t h e r m o r e 
t h e HLE-a P I l e v e l s (Method A) and t h e HLE-a M l e v e l s (Method B) 
d i d n o t c o r r e l a t e (R<0.1, F i g . 3 ) . 
I t must be s t r e s s e d t h a t t h e l e v e l s o f e l a s t a s e a c t i v i t y i n 
plasma a r e v e r y l o w , r e q u i r i n g a s e n s i t i v e assay and p r o l o n g e d 
r e a c t i o n t i m e s (see m e t h o d s ) . Normal plasma (n=24) h y d r o l y z e 
a p p r o x i m a t e l y 0.9 +_ 0.3 nmoles MeO-Suc-Ala-Ala-Pro-Val-pNA p e r 
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F i g . 3: HLE-a P I l e v e l s and HLE-a^M a c t i v i t i e s i n plasma o f 
87 RA p a t i e n t s ( n o t e l o g a r i t h m i c t r a n s f o r m a t i o n ) . 
ml p e r h o u r . A l t h o u g h an e x t r a p o l a t i o n f r o m t h i s v a l u e t o t h e 
amount o f enzyme a c t u a l l y p r e s e n t as a^M complex i s n o t p e r -
m i s s i b l e , i t can be e s t i m a t e d t o be ab o u t 1-2 ng e l a s t a s e / m l 
plasma. T h i s i s much l e s s t h a n t h e 84 ng e l a s t a s e / m l bound t o a P I 
i n n o r m a l plasma (see a b o v e ) . However, t h e s e v a l u e s a r e q u i t e 
c o m p a t i b l e , when t h e known r a t e s o f complex f o r m a t i o n and e l i m i -
n a t i o n a r e t a k e n i n t o a c c o u n t : t h e a s s o c i a t i o n r a t e c o n s t a n t o f 
e l a s t a s e / a P I i s 1.5 t o 2 f o l d h i g h e r t h a n t h a t o f e l a s t a s e / a ^ M 
( 2 7 ) ; t o g e t h e r w i t h t h e much h i g h e r plasma c o n c e n t r a t i o n o f a^PI 
(ap p r o x . 10 t i m e s i n m o l a r t e r m s ) t h i s a c c o u n t s f o r a 15-20 f o l d 
h i g h e r r a t e o f f o r m a t i o n o f t h e e l a s t a s e / a ^ P I complex compared 
w i t h t h e f o r m a t i o n o f t h e e l a s t a s e / a M complex i n plasma. I n d e e d , 
i t was f o u n d t h a t 90 % o f a s m a l l amount o f r a d i o l a b e l l e d e l a s t a s e 
added t o human serum was bound t o a ^ P I ( 2 8 ) . The h a l f - t i m e o f e l i -
m i n a t i o n o f e l a s t a s e - a ^ M complexes i n man i s approx. 12 m i n , t h a t 
o f e l a s t a s e -a P I i s ap p r o x . 60 min ( 2 9 ) . 
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U s i n g t h e s e numbers f o r a s i m p l e computer s i m u l a t i o n e x p e r i m e n t we 
c a l c u l a t e d an i n f l u x o f 47 ng/ml/h o f e l a s t a s e i n t o plasma ( o f h e a l t h y 
c o n t r o l s ) c r e a t i n g s t e a d y s t a t e l e v e l s o f e l a s t a s e bound t o o^Pl and 
t o Q^M o f 9 0 ng/ml and 0 . 9 ng/ml, r e s p e c t i v e l y , - s u r p r i s i n g l y c l o s e 
t o o u r e s t i m a t e d v a l u e s o f 8 4 and 1 t o 2 ng/ml. 
These c a l c u l a t i o n s , a l t h o u g h t o be i n t e r p r e t e d w i t h c a u t i o n , 
p o i n t t o a n o t h e r i m p o r t a n t c o n s i d e r a t i o n . The f l u x o f 47 ng o f 
e l a s t a s e p e r ml plasma p e r h o u r w o u l d i n d i c a t e a t o t a l t u r n o v e r o f 
HLE o f 2 t o 3 mg p e r day, w h i c h i s f a r below t h e e s t i m a t e d v a l u e o f 
3 0 0 - 4 0 0 mg e l a s t a s e assumed t o be r e l e a s e d as a consequence o f t h e 
n o r m a l l i f e span o f PMN l e u k o c y t e s i n h e a l t h y p e r s o n s ( 2 8 ) . I t must 
be c o n c l u d e d , t h e r e f o r e , t h a t o n l y a s m a l l p a r t o f t h e e l a s t a s e p r e -
s e n t i n t h e n e u t r o p h i l g r a n u l e s e v e r reaches t h e c i r c u l a t i o n . T h i s 
m i g h t be one r e a s o n f o r t h e l a c k o f c o r r e l a t i o n o f plasma HLE l e v e l s 
and d i s e a s e a c t i v i t y as o b s e r v e d h e r e . O t h e r reasons may be i n f l a m m a t -
i o n r e l a t e d a l t e r a t i o n o f t h e c l e a r a n c e r a t e ( r e t i c u l o e n d o t h e l i a l 
system) and a l t e r e d r a t e s o f s y n t h e s i s and c o n s u m p t i o n o f p r o t e i n a s e 
i n h i b i t o r s ( a ^ P I i s an a c u t e phase r e a c t a n t ) . 
I t i s c o n c l u d e d t h a t , a l t h o u g h HLE i s s u b s t a n t i a l l y e l e v a t e d i n 
t h e plasma o f many RA p a t i e n t s , t h e plasma c o n c e n t r a t i o n o f t h i s en-
zyme by i t s e l f c a n n o t s e r v e as an i n d i c a t o r o f d i s e a s e a c t i v i t y . I t 
i s p o s s i b l e , h o w e v e r , t h a t i n l o n g i t u d i n a l s t u d i e s ( w i t h i n t h e same 
p a t i e n t s ) changes i n plasma HLE l e v e l s may be i n d i c a t i v e o f d i s e a s e 
p r o g r e s s i o n ; i n d e e d , changes i n plasma l e v e l s o f HLE have p r e v i o u s l y 
been shown t o be i n d i c a t i v e o f d i s e a s e p r o g r e s s i o n i n s e p t i c a e m i a ( 1 7 ) . 
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